July 24, 2025 NOVATEC Pharmaceutical Company (part of MedSol Holding) I have successfully released the first trial batch of the drug Rivaxan, developed by the specialists of our company ACADEMPHARM.
On the same day, Vitaly Borchuk, Ambassador Extraordinary and Plenipotentiary of the Republic of Belarus to the Republic of Cuba, visited the factory. During the visit, he got acquainted with the production process and discussed further prospects for cooperation.
Rivaxan was certified in Cuba in April 2024, and the first samples will now be sent to potential customers — ministries, departments and organizations of Cuba.
The launch of mass production in Cuba is planned after the conclusion of long-term contracts with end users.
This event became a significant stage in the development of international cooperation and once again confirmed the high quality of domestic pharmaceutical developments.
Interesting in the press center
Delivery of Rivaxan to the National Health System of the Republic of Cuba
Candesartan-NAN – stability and duration of blood pressure control
Potential of RANOLAZINE in improving the quality of life of patients with coronary heart disease. – Download the article
Teambuilding 2020 at ACADEMPHARM: kayaking!